Director/PDMR Shareholding

| Filed in:
Tate & Lyle PLC (“the Company”) was informed on 2 March 2006 that on 2 March 2006 the following share transactions were completed by Mr Robert Gibber, the Company Secretary and General Counsel and a Person Discharging Managerial Responsibility in the Company. i) Mr Gibber exercised options over ordinary shares in the Company under the Tate & Lyle 1992 Executive Share Option Scheme as follows: - options over 4,750 ordinary shares at 483 pence per share; and - options over 5,000 ordinary shares at 470.5 pence per share. ii) Mr Gibber exercised options over ordinary shares in the Company under the Tate & Lyle 2000 Executive Share Option Scheme as follows: - options over 59,440 ordinary shares at 374.5 pence per share. He subsequently sold 56,000 ordinary shares at 601.95 pence per share to pay the acquisition costs, tax and National Insurance, and retained 13,190 ordinary shares. Following this transaction, Mr Gibber now has an interest in 34,692 shares in the Company. The notification of these transactions is intended to satisfy the Company’s obligations under both section 324 Companies Act 1985 and Disclosure Rule 3.1.2.

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled £2.8 billion. For more information, please visit or follow Tate & Lyle on Twitter or Linkedin.